帕拉米克索病毒聚合酶及其抑制剂的结构生物学研究进展
Jinyuan Wu1, Sining Tao1, An-Chao Ge1
1Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan, Shandong 250012, P.R. China.
开发针对帕拉米克索病毒的广泛抗病毒药物至关重要. 这项研究审查了paramyxovirus聚合酶结构和抑制剂,以指导新疗法的设计.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 帕拉米克索病毒,包括尼帕病毒和麻疹病毒,对全球健康构成重大威胁.
- 缺乏特定的治疗方法和疫苗挑战需要新的抗病毒策略.
- 帕拉米克索病毒聚合酶复合体是一个保存和必不可少的病毒标.
研究的目的:
- 为了综合最近的结构数据对帕拉米克索病毒聚合酶复合体.
- 分析共同点,独特特征和抑制机制.
- 识别可使用药物的地方,并提出合理的药物设计策略.
主要方法:
- 对帕拉米克索病毒聚合酶复合物的结构生物学研究的审查.
- 对针对聚合酶的现有抗病毒抑制剂的分析.
- 识别潜在的治疗点和药物设计方法.
主要成果:
- 详细的结构见解各种类型的paramyxovirus聚合酶复合体.
- 了解与药物向相关的保存和独特特征.
- 识别潜在的可用药物口袋和现有的抑制机制.
结论:
- 帕拉米克索病毒聚合酶复合体是广泛抗病毒药物开发的有希望的目标.
- 结构和机制的洞察力可以指导合理的药物设计.
- 这项工作为推进paramyxovirus治疗干预提供了基础.
更多相关视频
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
相关概念视频
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Bacterial RNA Polymerase
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
RNA Polymerase II Accessory Proteins
